Publications found:
36,694
Sort by:
Hepatic - Colorectal Metastasis - Pipeline Insight, 2020
US$ 1,250.00
This report can be delivered to the clients within 48-72 Hours Hepatic - Colorectal Metastasis Overview 'Hepatic - Colorectal Metastasis Pipeline Insight, 2020' Report By DelveInsight Outlays Compre...
January 2020
60 pages
Merrem PWS IV- Generic sale global - API Insight, 2020
US$ 500.00
This report can be delivered to the clients within 48 Hours 'Merrem PWS IV- Generic sale global - API Insight, 2020' report by DelveInsight provides product and API manufacturers details across US,...
January 2020
30 pages
Portal Hypertension - Pipeline Insight, 2020
US$ 1,250.00
This report can be delivered to the clients within 48-72 Hours Portal Hypertension Overview 'Portal Hypertension Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights Of Pres...
January 2020
60 pages
T-Bact - API Insight, 2020
US$ 500.00
This report can be delivered to the clients within 48 Hours 'T-Bact - API Insight, 2020' report by DelveInsight provides product and API manufacturers details across US, Europe, China and India for...
January 2020
30 pages
Anti-Rheumatics Market by Drug Class (Disease Modifying Anti-Rheumatic Drugs (DMARD's), Nonsteroidal Anti-Inflammatory Drugs (NSAID's), Corticosteroids, Uric Acid Drugs, and Others), Type (Prescription-Based Drugs and Over-the-Counter Drugs): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global anti-rheumatics market accounted for $57,229 million in 2018 and is expected to reach $71,934 million by 2026, registering a CAGR of 2.9% from 2019 to 2026. Rheumatoid arthritis (RA) is a c...
January 2020
202 pages
Immunosuppressants Market by Drug class (Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, and Others), Indication (Organ Transplantation, Autoimmune Disorders, and Non-Autoimmune Inflammatory Diseases), and Distribution channel (Hospital pharmacies, Retail pharmacies and Online pharmacies): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global immunosuppressants market was valued at $13,890.0 million in 2018 and is expected to reach $42,511.37 million by 2026, registering a CAGR of 14.7% from 2019 to 2026. Immunosuppressants supp...
January 2020
165 pages
GCC Pharmaceutical Market Opportunity Insight 2025
US$ 3,600.00
Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. 'GCC Pharmaceutical Market Opportunity Insight 2025' Report Highlights:GCC Pharmaceutical...
January 2020
300 pages
Glufosinate Market by Crop Type (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables, and Others), and Formulation Type (Aqueous Suspension, Liquid, Suspension Concentrate, Soluble (Liquid) Concentrate, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,540.00
... may hamper the growth of the market. The glufosinate market is segmented on the basis of crop type, which includes cereals & grains, ... competitive outlook of the global glufosinate market. GLUFOSINATE MARKET SEGMENT: The world glufosinate market is segmented as follows: By Crop Type Cereals & Grains Oilseeds & ...
December 2019
249 pages
Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Other Diseases): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
... for gene therapy and the high costs of gene therapy drugs are expected to hinder the growth of the market. The global gene therapy market is segmented based on vector type, gene type ...
December 2019
310 pages
Antihypertensive Drugs Market by Therapeutic Class (Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others Distribution Channel): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
The global antihypertensive market accounted for $22,557 million in 2018, and is expected to reach $28,797 million by 2026, registering a CAGR of 3.1% from 2019 to 2026. Antihypertensive drugs are emp...
December 2019
222 pages
